icon-folder.gif   Conference Reports for NATAP  
 
  EASL 47th Annual Meeting
April 18th - 22nd 2012
Barcelona, Spain
Back grey_arrow_rt.gif
 
 
 
Futility Rules in Telaprevir Combination Treatment
 
 
  Reported by Jules Levin
EASL 2012 Apr 18-22 Barcelona Spain
 
Ira M. Jacobson1, Doug J. Bartels2, Linda Gritz2, Tara L. Kieffer2, Sandra De Meyer3, Frank Tomaka4, Leif Bengtsson2, Don Luo4, Bambang S. Adiwijaya2, Robert S. Kauffman2, Gaston Picchio4, Nathalie Adda2
 
1Weill Cornell Medical College, New York, NY, United States; 2Vertex Pharmaceuticals Incorporated, Cambridge, MA, United States; 3Janssen Infectious Diseases BVBA, Beerse, Belgium; 4Janssen Research and Development, LLC, Titusville, New Jersey, United States

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif

EASL11.gif